Cosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 4,520,000 common share at an issue price of KRW 1,330 per share for gross proceeds of KRW 6,011,600,000 on February 10, 2021. The transaction will include participation from returning investor, Icure Pharmaceutical Incorporation (KOSDAQ:A175250). The face value of the shares to be issued is KRW 500 per share.

The company will raise funds through third party allocation method. The shares to be issued will have a hold period of one year, post the closing. The payment date is on February 25, 2021.

The transaction has been approved by the board of directors of the company.